 |
|
|
 |
 |
 |
3rd US-Japan Biostatistics
Workshop
- Preliminary Agenda -
|
| |
October 7, 2005
Inamori Hall, Faculty of Medicine, Kyoto University |
|
|
|
|
OPENING REMARKS
| 9:00 a.m. |
 |
Masanori Fukushima, M.D., Ph.D.,
Kyoto University & Translational Research Informatics
Center |
|
CLINICAL TRIALS
| 9:10 a.m. |
Inter-Patient Variability
and Misspecification of Dose-Response Modeling in CRM
 |
Naoki Ishizuka, Ph.D.,
International Medical Center of Japan |
|
| 9:30 a.m. |
Bayesian Sequential Analysis in Translational
Research
 |
Satoshi Teramukai, Ph.D.,
Kyoto University & Translational Research Informatics
Center |
|
| 9:50 a.m. |
The Mean Squared Error D-Optimum
Design for Selection of Sampling Times in Pharmacokinetics
 |
Takashi Daimon, Ph.D.,
University of Shizuoka |
|
| 10:10 a.m. |
Break |
| 10:20 a.m. |
Designs for Trials of Personalized
Therapy Based on Chemosensitivity
 |
Seiichiro Yamamoto, Ph.D.,
National Cancer Center |
|
| 10:40 a.m. |
Designs for Trials of Targeted Therapy
in Oncology
 |
John Crowley, Ph.D.,
Cancer Research And Biostatistics |
|
| 11:00 a.m. |
Analysis of Neurotoxicity of Taxane
 |
Yasuo Ohashi, Ph.D.,
University of Tokyo |
|
| 11:20 a.m. |
Break |
OBSERVATIONAL ANALYSIS & CAUSAL INFERENCE
| 11:30 a.m. |
Comparison of Efficiency
among Estimation Methods in Case-Control Studies within Cohort
 |
Sachiko Tanaka, Ph.D. and Seiichiro
Yamamoto, Ph.D.,
National Cancer Center |
|
| 11:50 a.m. |
Randomized-Based Analysis of All
Eligible Patients Adaptive to Protocol Amendment of Eligibility
Criteria
 |
Kenichi Yoshimura, Ph.D.,
National Cancer Center |
|
| 12:10 p.m. |
A Sensitivity Analysis for Unmeasured
Confounding on the Estimation of Causal Effect
 |
Yasutaka Chiba, Ph.D., Yutaka Matsuyama,
Ph.D., and Tosiya Sato, Ph.D.,
Kyoto University |
|
| 12:30 p.m. |
Lunch |
KEYNOTE LECTURE: COMPUTATIONAL BIOLOGY
| 2:00 p.m. |
An Overview of the Bioconductor
Project and Applications in Computational Biology
 |
Robert Gentleman, Ph.D.,
Fred Hutchinson Cancer Research Center |
|
| 2:40 p.m. |
Break |
GENE EXPRESSION PROFILING
| 3:00 p.m. |
Use of High Throughput
Genomics in a Large Single Institution Trial to Predict Survival
of Patients with Myeloma
 |
John Shaughnessy, Ph.D.
Myeloma Institute for Research and Therapy, University
of Arkansas for Medical Sciences |
|
| 3:20 p.m. |
Comparison of Prognostic Prediction
Methods using Subsets of Significant Genes
 |
Takeharu Yamanaka, Ph.D.,
Translational Research Informatics Center |
|
| 3:40 p.m. |
Sample Size Calculations for Selecting
Differentially Expressed Genes Based on Gene Ranking
 |
Shigeyuki Matsui, Ph.D.,
Kyoto University & Translational Research Informatics
Center |
|
| 4:00 p.m. |
Break |
PROGNOSTIC FACTORS AND BIOMARKERS
| 4:10 p.m. |
Prognostic Modeling using
Stage-wise Methods
 |
Michael LeBlanc, Ph.D.,
Fred Hutchinson Cancer Research Center |
|
| 4:30 p.m. |
Operating Characteristics of Prostate-Specific
Antigen: Results from the Prostate Cancer Prevention Trial
 |
Donna Pauler Ankerst, Ph.D.,
Sylvia Lawry Center for MS Research |
|
CLOSING REMARKS
| 4:50 p.m. |
 |
John Crowley, Ph.D.,
Cancer Research And Biostatistics |
|
|
|
|
 |
本サイトの掲載内容の無断転載を禁じます。
Copyright c 2007 Div. Clinical Trial Design & Management,
Translational Research Center, Kyoto University Hospital. All
Rights Reserved. |
|
|